| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 2.69e-05 | 114 | 152 | 7 | GO:0004843 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 4.61e-05 | 124 | 152 | 7 | GO:0101005 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 8.68e-05 | 137 | 152 | 7 | GO:0019783 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 3.42e-04 | 4 | 152 | 2 | GO:0030197 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 8.18e-06 | 6 | 157 | 3 | GO:0033165 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 1.93e-04 | 111 | 157 | 6 | GO:0001750 | |
| Domain | USP_1 | 1.61e-06 | 70 | 152 | 7 | PS00972 | |
| Domain | UCH | 1.77e-06 | 71 | 152 | 7 | PF00443 | |
| Domain | USP_2 | 1.77e-06 | 71 | 152 | 7 | PS00973 | |
| Domain | USP_3 | 1.95e-06 | 72 | 152 | 7 | PS50235 | |
| Domain | USP_dom | 1.95e-06 | 72 | 152 | 7 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.95e-06 | 72 | 152 | 7 | IPR001394 | |
| Domain | SEA | 3.96e-06 | 14 | 152 | 4 | SM00200 | |
| Domain | HABP4_PAI-RBP1 | 7.11e-06 | 16 | 152 | 4 | PF04774 | |
| Domain | HABP4_PAIRBP1-bd | 7.11e-06 | 16 | 152 | 4 | IPR006861 | |
| Domain | USP_CS | 1.60e-05 | 66 | 152 | 6 | IPR018200 | |
| Domain | Coatomer/calthrin_app_sub_C | 2.87e-05 | 8 | 152 | 3 | IPR009028 | |
| Domain | SEA | 3.31e-05 | 23 | 152 | 4 | PS50024 | |
| Domain | SEA_dom | 3.31e-05 | 23 | 152 | 4 | IPR000082 | |
| Domain | Coatomer_g_Cpla | 6.58e-05 | 2 | 152 | 2 | IPR032154 | |
| Domain | - | 6.58e-05 | 2 | 152 | 2 | 2.60.40.1480 | |
| Domain | COP-gamma_platf | 6.58e-05 | 2 | 152 | 2 | PF08752 | |
| Domain | Coatomer_g_Cpla | 6.58e-05 | 2 | 152 | 2 | PF16381 | |
| Domain | Coatomer_gsu_app_Ig-like-sub | 6.58e-05 | 2 | 152 | 2 | IPR013040 | |
| Domain | ZF_CCHC_HIVEP | 6.58e-05 | 2 | 152 | 2 | PS51811 | |
| Domain | Coatomer_gsu | 6.58e-05 | 2 | 152 | 2 | IPR017106 | |
| Domain | EGF-like_dom | 2.06e-04 | 249 | 152 | 9 | IPR000742 | |
| Domain | Clathrin/coatomer_adapt-like_N | 2.24e-04 | 15 | 152 | 3 | IPR002553 | |
| Domain | - | 2.24e-04 | 15 | 152 | 3 | 3.30.70.960 | |
| Domain | Adaptin_N | 2.24e-04 | 15 | 152 | 3 | PF01602 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 3.91e-04 | 4 | 152 | 2 | IPR015873 | |
| Domain | DUF3371 | 3.91e-04 | 4 | 152 | 2 | PF11851 | |
| Domain | MiT/TFE_C | 3.91e-04 | 4 | 152 | 2 | IPR021802 | |
| Domain | - | 3.91e-04 | 4 | 152 | 2 | 3.30.310.30 | |
| Domain | EGF | 6.91e-04 | 235 | 152 | 8 | SM00181 | |
| Domain | EGF_3 | 6.91e-04 | 235 | 152 | 8 | PS50026 | |
| Domain | SEA | 7.26e-04 | 22 | 152 | 3 | PF01390 | |
| Domain | EGF-like_CS | 1.36e-03 | 261 | 152 | 8 | IPR013032 | |
| Domain | EGF_2 | 1.49e-03 | 265 | 152 | 8 | PS01186 | |
| Domain | GPCR_Rhodpsn_7TM | GPR4 OR1J1 OR13C5 OR13C3 LGR4 RXFP3 PTGER4 OR1J4 OR1J2 OR13C9 OR1I1 OR2AT4 OR13C2 | 3.31e-03 | 670 | 152 | 13 | IPR017452 |
| Domain | 7tm_1 | GPR4 OR1J1 OR13C5 OR13C3 LGR4 RXFP3 PTGER4 OR1J4 OR1J2 OR13C9 OR1I1 OR2AT4 OR13C2 | 3.62e-03 | 677 | 152 | 13 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | GPR4 OR1J1 OR13C5 OR13C3 LGR4 RXFP3 PTGER4 OR1J4 OR1J2 OR13C9 OR1I1 OR2AT4 OR13C2 | 3.99e-03 | 685 | 152 | 13 | PS00237 |
| Domain | Coatomer/clathrin_app_Ig-like | 4.12e-03 | 12 | 152 | 2 | IPR013041 | |
| Domain | C8 | 4.12e-03 | 12 | 152 | 2 | PF08742 | |
| Domain | TIL | 4.12e-03 | 12 | 152 | 2 | PF01826 | |
| Domain | G_PROTEIN_RECEP_F1_2 | GPR4 OR1J1 OR13C5 OR13C3 LGR4 RXFP3 PTGER4 OR1J4 OR1J2 OR13C9 OR1I1 OR2AT4 OR13C2 | 4.29e-03 | 691 | 152 | 13 | PS50262 |
| Domain | GPCR_Rhodpsn | GPR4 OR1J1 OR13C5 OR13C3 LGR4 RXFP3 PTGER4 OR1J4 OR1J2 OR13C9 OR1I1 OR2AT4 OR13C2 | 4.34e-03 | 692 | 152 | 13 | IPR000276 |
| Domain | Unchr_dom_Cys-rich | 4.84e-03 | 13 | 152 | 2 | IPR014853 | |
| Domain | C8 | 4.84e-03 | 13 | 152 | 2 | SM00832 | |
| Domain | EGF_1 | 4.93e-03 | 255 | 152 | 7 | PS00022 | |
| Domain | Olfact_rcpt | 4.95e-03 | 393 | 152 | 9 | IPR000725 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.62e-03 | 14 | 152 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.62e-03 | 14 | 152 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.62e-03 | 14 | 152 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.62e-03 | 14 | 152 | 2 | PF08393 | |
| Domain | TIL_dom | 5.62e-03 | 14 | 152 | 2 | IPR002919 | |
| Domain | ATPase_dyneun-rel_AAA | 5.62e-03 | 14 | 152 | 2 | IPR011704 | |
| Domain | MT | 5.62e-03 | 14 | 152 | 2 | PF12777 | |
| Domain | AAA_8 | 5.62e-03 | 14 | 152 | 2 | PF12780 | |
| Domain | uDENN | 5.62e-03 | 14 | 152 | 2 | SM00800 | |
| Domain | AAA_5 | 5.62e-03 | 14 | 152 | 2 | PF07728 | |
| Domain | DHC_fam | 6.44e-03 | 15 | 152 | 2 | IPR026983 | |
| Domain | uDENN | 6.44e-03 | 15 | 152 | 2 | PF03456 | |
| Domain | Dynein_heavy | 6.44e-03 | 15 | 152 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.44e-03 | 15 | 152 | 2 | IPR004273 | |
| Domain | DENN | 7.33e-03 | 16 | 152 | 2 | SM00799 | |
| Domain | VWF_type-D | 7.33e-03 | 16 | 152 | 2 | IPR001846 | |
| Domain | DENN | 7.33e-03 | 16 | 152 | 2 | PF02141 | |
| Domain | VWFD | 7.33e-03 | 16 | 152 | 2 | PS51233 | |
| Domain | dDENN | 7.33e-03 | 16 | 152 | 2 | PF03455 | |
| Domain | UDENN | 7.33e-03 | 16 | 152 | 2 | PS50946 | |
| Domain | DDENN | 7.33e-03 | 16 | 152 | 2 | PS50947 | |
| Domain | VWD | 7.33e-03 | 16 | 152 | 2 | SM00216 | |
| Domain | dDENN | 7.33e-03 | 16 | 152 | 2 | SM00801 | |
| Domain | dDENN_dom | 7.33e-03 | 16 | 152 | 2 | IPR005112 | |
| Domain | uDENN_dom | 7.33e-03 | 16 | 152 | 2 | IPR005113 | |
| Domain | DENN | 7.33e-03 | 16 | 152 | 2 | PS50211 | |
| Domain | DENN_dom | 7.33e-03 | 16 | 152 | 2 | IPR001194 | |
| Domain | VWD | 7.33e-03 | 16 | 152 | 2 | PF00094 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 4.75e-06 | 16 | 104 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 6.18e-06 | 17 | 104 | 4 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.22e-05 | 23 | 104 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 3.69e-05 | 26 | 104 | 4 | M27483 | |
| Pubmed | TSHZ3 HIVEP1 TTC28 BCORL1 COPG2 RREB1 ANKHD1 JMJD1C LUZP1 ALMS1 BRCA2 GEMIN4 CUX1 KNL1 | 9.15e-09 | 418 | 159 | 14 | 34709266 | |
| Pubmed | USP36 ANK3 TTC28 COPG1 LGR4 MUC16 GPRIN3 COPG2 CCT4 RYR2 CDCA2 LRIG2 AP4E1 RIF1 SLC12A2 TENM3 MPHOSPH9 CUX1 | 2.03e-08 | 777 | 159 | 18 | 35844135 | |
| Pubmed | AMPD1 HIVEP1 TTC28 TNC BCORL1 MUC16 TMEM200A RYR2 TFE3 NCOA1 MCRS1 CUX1 LRRC41 KNL1 AHNAK2 DNAH11 | 4.43e-08 | 638 | 159 | 16 | 31182584 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | USP36 NUP50 HIVEP1 SALL3 BCORL1 DACH1 COPG2 RREB1 JMJD1C LUZP1 CDCA2 RIF1 BRCA2 FANCI ACIN1 RPRD2 C2orf49 CUX1 KNL1 | 8.64e-08 | 954 | 159 | 19 | 36373674 |
| Pubmed | Organization and evolutionary relatedness of OR37 olfactory receptor genes in mouse and human. | 2.02e-07 | 12 | 159 | 4 | 12906860 | |
| Pubmed | Gene expression in the developing mouse retina by EST sequencing and microarray analysis. | 3.19e-07 | 142 | 159 | 8 | 11812828 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TSHZ3 HIVEP1 BACH2 BCORL1 RREB1 JMJD1C CDCA2 PRKAG1 GEMIN4 NCOA1 USP54 CUX1 | 3.36e-07 | 398 | 159 | 12 | 35016035 |
| Pubmed | MAP9 STARD8 SALL3 ANK3 KRT84 ASH1L LGR4 COPG2 SALL4 DEPDC1 TACC2 FRYL ANKHD1 WDFY4 VCAN PGAP1 ACIN1 TMEM131 TAPBP | 6.03e-07 | 1084 | 159 | 19 | 11544199 | |
| Pubmed | HNF1A TSHZ3 HIVEP1 NACA BCORL1 DACH1 CCT4 MAP7 RREB1 ANKHD1 JMJD1C TFE3 CDCA2 RIF1 ALMS1 NCOA1 MCRS1 RPRD2 USP54 CUX1 FOXI1 SORL1 | 6.50e-07 | 1429 | 159 | 22 | 35140242 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.22e-06 | 18 | 159 | 4 | 18834073 | |
| Pubmed | 1.39e-06 | 233 | 159 | 9 | 37704626 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.67e-06 | 123 | 159 | 7 | 26912792 | |
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 11884415 | ||
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 2.18e-06 | 82 | 159 | 6 | 31073041 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | 2.37e-06 | 21 | 159 | 4 | 8622927 | |
| Pubmed | 2.37e-06 | 21 | 159 | 4 | 14583620 | ||
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | 2.37e-06 | 21 | 159 | 4 | 11468161 | |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | 2.37e-06 | 21 | 159 | 4 | 8756639 | |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | 2.37e-06 | 21 | 159 | 4 | 12447969 | |
| Pubmed | 2.37e-06 | 21 | 159 | 4 | 18980247 | ||
| Pubmed | 2.89e-06 | 22 | 159 | 4 | 9154835 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.00e-06 | 256 | 159 | 9 | 33397691 | |
| Pubmed | DMXL2 STARD8 GPRIN3 WDFY4 JMJD1C TMEM200A LRIG2 HIVEP3 ALMS1 CDK13 SV2C DOP1A | 3.13e-06 | 493 | 159 | 12 | 15368895 | |
| Pubmed | 3.74e-06 | 263 | 159 | 9 | 34702444 | ||
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | 4.16e-06 | 24 | 159 | 4 | 8995226 | |
| Pubmed | 4.94e-06 | 25 | 159 | 4 | 21115691 | ||
| Pubmed | 5.81e-06 | 26 | 159 | 4 | 35816173 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | LGR4 TACC2 FRYL MAP7 JMJD1C RIF1 GZF1 TENM3 RAB3IP USP32 MPHOSPH9 CUX1 | 7.29e-06 | 536 | 159 | 12 | 15840001 |
| Pubmed | LGR4 TACC2 FRYL MAP7 JMJD1C RIF1 GZF1 TENM3 RAB3IP USP32 MPHOSPH9 CUX1 | 7.57e-06 | 538 | 159 | 12 | 10512203 | |
| Pubmed | 9.14e-06 | 29 | 159 | 4 | 32527007 | ||
| Pubmed | GABRG2 MAP9 INTU PCDHGB7 KRT84 ASH1L CCT4 TEX14 RYR2 LUZP1 CDCA2 MLIP CDK13 ANKRD30A ACIN1 DLEC1 BTNL9 CUX1 DOP1A FCMR | 1.03e-05 | 1442 | 159 | 20 | 35575683 | |
| Pubmed | 1.51e-05 | 11 | 159 | 3 | 36613751 | ||
| Pubmed | USP36 INTU MAP1A TTC28 BACH2 ASH1L LGR4 MAP7 RREB1 ANKHD1 LUZP1 ALMS1 MCRS1 USP54 LRRC41 KNL1 SORL1 | 1.53e-05 | 1116 | 159 | 17 | 31753913 | |
| Pubmed | 1.55e-05 | 33 | 159 | 4 | 20228807 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | INTU ANK3 PCDH11Y RALGAPB ASH1L FRYL COG3 JMJD1C DNAH1 HIVEP3 CDK13 RAB3IP PRKAG1 MAST1 RPRD2 CUX1 DOP1A LRRC41 CREB3L2 PDZD2 | 1.64e-05 | 1489 | 159 | 20 | 28611215 |
| Pubmed | 1.75e-05 | 34 | 159 | 4 | 20403174 | ||
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | 1.75e-05 | 34 | 159 | 4 | 14699124 | |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | 1.75e-05 | 34 | 159 | 4 | 15780755 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | 1.75e-05 | 34 | 159 | 4 | 19188362 | |
| Pubmed | 1.75e-05 | 34 | 159 | 4 | 11941478 | ||
| Pubmed | 1.75e-05 | 34 | 159 | 4 | 17109758 | ||
| Pubmed | 1.75e-05 | 34 | 159 | 4 | 20388806 | ||
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | 1.75e-05 | 34 | 159 | 4 | 20715989 | |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | 1.75e-05 | 34 | 159 | 4 | 9806828 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | 1.75e-05 | 34 | 159 | 4 | 20368735 | |
| Pubmed | 1.75e-05 | 34 | 159 | 4 | 10936051 | ||
| Pubmed | 1.75e-05 | 34 | 159 | 4 | 21448158 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HIVEP1 MAP1A TTC28 BACH2 BCORL1 TACC2 MAP7 LUZP1 ALMS1 BRCA2 KNL1 SORL1 | 1.83e-05 | 588 | 159 | 12 | 38580884 |
| Pubmed | INTU NRCAM TTC28 RALGAPB ZNF365 TENM3 MAST1 ACIN1 RUBCN PDZD2 | 1.96e-05 | 407 | 159 | 10 | 12693553 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | 1.97e-05 | 35 | 159 | 4 | 16611142 | |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | 1.97e-05 | 35 | 159 | 4 | 21239494 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TFEC HNF1A TSHZ3 HIVEP1 BACH2 ASH1L RREB1 TFE3 HIVEP3 FOXD3 NCOA1 DMRTA1 MYRF FOXI1 CREB3L2 | 1.98e-05 | 908 | 159 | 15 | 19274049 |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 16493581 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 11467950 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 36078128 | ||
| Pubmed | Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133. | 2.08e-05 | 2 | 159 | 2 | 17185982 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 24360805 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 8336698 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 15073129 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 28842428 | ||
| Pubmed | The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity. | 2.08e-05 | 2 | 159 | 2 | 26308623 | |
| Pubmed | 2.21e-05 | 36 | 159 | 4 | 20147298 | ||
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | 2.47e-05 | 37 | 159 | 4 | 20228808 | |
| Pubmed | 3.48e-05 | 268 | 159 | 8 | 33640491 | ||
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 3.94e-05 | 442 | 159 | 10 | 15815621 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP1 TTC28 RALGAPB KCTD8 FRYL MAP7 LUZP1 CDCA2 SLC12A2 ALMS1 MPHOSPH9 USP54 DOP1A AHNAK2 | 4.48e-05 | 861 | 159 | 14 | 36931259 |
| Pubmed | 6.17e-05 | 147 | 159 | 6 | 29576527 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 21041274 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 10512748 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 31368666 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 23386199 | ||
| Pubmed | Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue. | 6.21e-05 | 3 | 159 | 2 | 20422702 | |
| Pubmed | Mechanism of RAD51-dependent DNA interstrand cross-link repair. | 6.21e-05 | 3 | 159 | 2 | 21719678 | |
| Pubmed | Interaction of gamma-COP with a transport motif in the D1 receptor C-terminus. | 6.21e-05 | 3 | 159 | 2 | 11893085 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 21037323 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 11818452 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 27230679 | ||
| Pubmed | Anti-inflammatory genes associated with multiple sclerosis: a gene expression study. | 6.21e-05 | 3 | 159 | 2 | 25670004 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 32640908 | ||
| Pubmed | Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances. | 6.21e-05 | 3 | 159 | 2 | 27757953 | |
| Pubmed | Genome-wide RNAi screen for nuclear actin reveals a network of cofilin regulators. | 6.21e-05 | 3 | 159 | 2 | 26021350 | |
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 28684355 | ||
| Pubmed | 6.21e-05 | 3 | 159 | 2 | 21173574 | ||
| Pubmed | Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain. | 7.27e-05 | 18 | 159 | 3 | 31910261 | |
| Pubmed | 7.43e-05 | 152 | 159 | 6 | 38360978 | ||
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 8.22e-05 | 50 | 159 | 4 | 31806660 | |
| Pubmed | 8.38e-05 | 225 | 159 | 7 | 12168954 | ||
| Pubmed | Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. | 8.61e-05 | 19 | 159 | 3 | 30385546 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ANK3 COPG1 ASH1L GPRIN3 COPG2 CCT4 MUC5B COG3 TMEM200A DNAH1 HIVEP3 SLC12A2 AHNAK2 | 9.27e-05 | 807 | 159 | 13 | 30575818 |
| Pubmed | 9.31e-05 | 396 | 159 | 9 | 26687479 | ||
| Pubmed | HNF1A HIVEP1 SALL3 BACH2 ASH1L SALL4 TFE3 HIVEP3 RIF1 NCOA1 ACIN1 CUX1 CREB3L2 | 9.38e-05 | 808 | 159 | 13 | 20412781 | |
| Pubmed | 1.04e-04 | 101 | 159 | 5 | 18519826 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | USP36 NUP50 MAP1A NACA COPG2 CCT4 TACC2 ANKHD1 RIF1 ALMS1 ACIN1 RPRD2 KNL1 AHNAK2 | 1.06e-04 | 934 | 159 | 14 | 33916271 |
| Pubmed | 1.13e-04 | 164 | 159 | 6 | 32409323 | ||
| Pubmed | 1.15e-04 | 503 | 159 | 10 | 16964243 | ||
| Pubmed | 1.17e-04 | 21 | 159 | 3 | 19596656 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TSHZ3 HIVEP1 BCORL1 RREB1 JMJD1C CDCA2 RIF1 FANCI WDR12 CUX1 LRRC41 | 1.20e-04 | 608 | 159 | 11 | 36089195 |
| Pubmed | Regulation and function of Spalt proteins during animal development. | 1.24e-04 | 4 | 159 | 2 | 19247946 | |
| Pubmed | 1.24e-04 | 4 | 159 | 2 | 35192681 | ||
| Pubmed | Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia. | 1.24e-04 | 4 | 159 | 2 | 18492703 | |
| Cytoband | 9q31.1 | 1.27e-05 | 41 | 159 | 4 | 9q31.1 | |
| GeneFamily | CD molecules|Mucins | 6.66e-06 | 21 | 108 | 4 | 648 | |
| GeneFamily | Olfactory receptors, family 13 | 9.77e-06 | 23 | 108 | 4 | 162 | |
| GeneFamily | Olfactory receptors, family 1 | 9.32e-05 | 40 | 108 | 4 | 147 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | TFEC HIVEP1 ERAP1 TMEM200A SLCO5A1 RIF1 FANCI VCAN PGAP1 MPHOSPH9 KNL1 | 2.31e-06 | 305 | 156 | 11 | M19875 |
| Coexpression | MURARO_PANCREAS_DELTA_CELL | 2.70e-06 | 250 | 156 | 10 | M39170 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | SALL3 NRCAM MAP1A DACH1 SALL4 NCKAP5 FRYL ZBTB12 MAP7 LUZP1 SLCO5A1 PROM1 RIF1 ALMS1 BRCA2 DMRTA1 MPHOSPH9 KNL1 | 7.28e-09 | 498 | 143 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | INTU SALL3 NRCAM MAP1A DACH1 SALL4 NCKAP5 FRYL ZBTB12 MAP7 ANKHD1 LUZP1 SLCO5A1 PROM1 RIF1 ALMS1 BRCA2 PGAP1 MAST1 DMRTA1 MPHOSPH9 CUX1 KNL1 | 1.95e-07 | 989 | 143 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | DMXL2 ASH1L DACH1 NCKAP5 ZBTB12 COG3 ANKHD1 LUZP1 PROM1 RIF1 ALMS1 BRCA2 PGAP1 DMRTA1 MPHOSPH9 C2orf49 TAPBP CUX1 KNL1 | 3.23e-06 | 831 | 143 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | SALL3 TNC BACH2 DACH1 SALL4 NCKAP5 DEPDC1 COG3 RREB1 ZNF365 CDCA2 TMEM132C SLCO5A1 RIF1 SLC12A2 VCAN DMRTA1 RPRD2 CUX1 | 3.52e-06 | 836 | 143 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 4.85e-05 | 192 | 143 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | DMXL2 NEXMIF TEX14 RYR2 RIF1 SLC12A2 PLA1A SLC6A20 DMRTA1 NDRG4 NLRP5 | 5.34e-05 | 379 | 143 | 11 | gudmap_developingGonad_P2_ovary_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#3_top-relative-expression-ranked_500 | 6.63e-05 | 63 | 143 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 1.03e-04 | 69 | 143 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | SALL3 NRCAM MAP1A TNC DACH1 SALL4 ZBTB12 MAP7 LUZP1 PROM1 RIF1 ALMS1 BRCA2 MAST1 DMRTA1 RUBCN CUX1 DOP1A | 1.11e-04 | 983 | 143 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_100 | 1.28e-04 | 15 | 143 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_100_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | SALL3 NRCAM MAP1A SALL4 ZBTB12 MAP7 LUZP1 PROM1 RIF1 BRCA2 MAST1 DMRTA1 | 1.30e-04 | 493 | 143 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 1.53e-04 | 75 | 143 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | TNC DACH1 SALL4 DEPDC1 ZNF365 LEPR TMEM132C SLCO5A1 RIF1 DMRTA1 CUX1 | 1.57e-04 | 428 | 143 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | TTC28 TNC DACH1 NCKAP5 DEPDC1 MAP7 CDCA2 PROM1 SLC12A2 ALMS1 TENM3 VCAN RAB3IP KNL1 PDZD2 | 1.65e-04 | 749 | 143 | 15 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | TNC BACH2 DACH1 SALL4 NCKAP5 DEPDC1 RREB1 ZNF365 LEPR TMEM132C SLCO5A1 RIF1 VCAN DMRTA1 CUX1 SORL1 | 2.00e-04 | 850 | 143 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | B cells, B.FrE.FL, AA4.1+ IgM+ CD19+ CD43- CD24+, Fetal Liver, avg-3 | 2.19e-04 | 372 | 143 | 10 | GSM538204_500 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | BACH2 DEPDC1 CDCA2 FANCI PGAP1 TMEM131 RUBCN KNL1 PDZD2 FCMR | 2.60e-04 | 380 | 143 | 10 | GSM538207_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BCORL1 DACH1 ZBTB12 MAP7 LUZP1 CDCA2 PROM1 RIF1 ALMS1 BRCA2 ACIN1 MPHOSPH9 | 2.63e-04 | 532 | 143 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.65e-04 | 311 | 143 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_100 | 2.75e-04 | 85 | 143 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | DMXL2 NEXMIF ASH1L TEX14 RYR2 RIF1 SLC12A2 DMRTA1 NDRG4 NLRP5 | 3.00e-04 | 387 | 143 | 10 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | 3.39e-04 | 393 | 143 | 10 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.82e-04 | 327 | 143 | 9 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.08e-04 | 199 | 143 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | MAP9 NRCAM TNC BACH2 ASH1L DACH1 SALL4 RYR2 TMEM132C SLCO5A1 RIF1 SLC12A2 VCAN RPRD2 CUX1 | 4.21e-04 | 818 | 143 | 15 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 4.46e-04 | 407 | 143 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_200 | 4.80e-04 | 23 | 143 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_200 | 4.80e-04 | 54 | 143 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | TNC NCKAP5 DEPDC1 COG3 RREB1 ZNF365 CDCA2 RIF1 SLC12A2 VCAN DMRTA1 | 5.12e-04 | 492 | 143 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_200 | 5.46e-04 | 24 | 143 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 5.47e-04 | 209 | 143 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | DENND2A TSHZ3 NRCAM TNC BACH2 RYR2 HIVEP3 SLCO5A1 TENM3 VCAN PGAP1 | 8.82e-11 | 191 | 157 | 11 | 08720998aa55131d7377c4c67c4c935865bd7d79 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | DENND2A TSHZ3 TTC28 TNC BACH2 DACH1 RYR2 TMEM132C VCAN PCDH15 | 1.90e-09 | 194 | 157 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.89e-08 | 183 | 157 | 9 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-08 | 190 | 157 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.99e-08 | 193 | 157 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.72e-08 | 198 | 157 | 9 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.04e-08 | 157 | 157 | 8 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.67e-07 | 170 | 157 | 8 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.81e-07 | 182 | 157 | 8 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-07 | 191 | 157 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-07 | 192 | 157 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.22e-07 | 192 | 157 | 8 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 5.13e-07 | 197 | 157 | 8 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.13e-07 | 197 | 157 | 8 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 5.13e-07 | 197 | 157 | 8 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.25e-07 | 135 | 157 | 7 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.53e-07 | 199 | 157 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-07 | 199 | 157 | 8 | ccd473accf2205c120c0d32031619e421558a861 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-07 | 199 | 157 | 8 | 9735a1dc10910f02f1106b20ae5ab4c09c21305e | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-06 | 108 | 157 | 6 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-06 | 108 | 157 | 6 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | Dividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.98e-06 | 175 | 157 | 7 | 0a8bf455babb3271aa00642199fb58b0b02dc3ac | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.33e-06 | 178 | 157 | 7 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-06 | 179 | 157 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.46e-06 | 179 | 157 | 7 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-06 | 180 | 157 | 7 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-06 | 180 | 157 | 7 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.86e-06 | 182 | 157 | 7 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.86e-06 | 182 | 157 | 7 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 184 | 157 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 184 | 157 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.15e-06 | 184 | 157 | 7 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 4.15e-06 | 184 | 157 | 7 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 184 | 157 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.30e-06 | 185 | 157 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.30e-06 | 185 | 157 | 7 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.30e-06 | 185 | 157 | 7 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.30e-06 | 185 | 157 | 7 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.30e-06 | 185 | 157 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.30e-06 | 185 | 157 | 7 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.61e-06 | 187 | 157 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | Endothelial-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.61e-06 | 187 | 157 | 7 | fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.61e-06 | 187 | 157 | 7 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.61e-06 | 187 | 157 | 7 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.61e-06 | 187 | 157 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.78e-06 | 188 | 157 | 7 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.12e-06 | 190 | 157 | 7 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 5.12e-06 | 190 | 157 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.49e-06 | 192 | 157 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.49e-06 | 192 | 157 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.49e-06 | 192 | 157 | 7 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.49e-06 | 192 | 157 | 7 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.49e-06 | 192 | 157 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.68e-06 | 193 | 157 | 7 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.68e-06 | 193 | 157 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.68e-06 | 193 | 157 | 7 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.87e-06 | 194 | 157 | 7 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.87e-06 | 194 | 157 | 7 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.02e-06 | 73 | 157 | 5 | cc89c94a3768b02036757dea86989d9284b214b9 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.02e-06 | 73 | 157 | 5 | 6f28d52700bab981c8a3664ba4762f3572f7e788 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sfrp2-Inhibitory_Neuron.Gad1Gad2_Id2.Sfrp2_(Interneuron,_Neurogliaform1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.02e-06 | 73 | 157 | 5 | ae80fcf3544c18fe0318a8311e96f2448f7cb03c | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.07e-06 | 195 | 157 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 6.07e-06 | 195 | 157 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.07e-06 | 195 | 157 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.28e-06 | 196 | 157 | 7 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 6.28e-06 | 196 | 157 | 7 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | Skin-Tubules|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 6.28e-06 | 196 | 157 | 7 | 12e21cc310a261407b46e034108e8c93ea16e045 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.28e-06 | 196 | 157 | 7 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.49e-06 | 197 | 157 | 7 | 749e0e332644543cbdf2ee38c2b301ce0a019a7f | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 6.49e-06 | 197 | 157 | 7 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.93e-06 | 199 | 157 | 7 | f315ec3fb6c0799668c9195f836a77fc0db2b615 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.93e-06 | 199 | 157 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.16e-06 | 200 | 157 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.16e-06 | 200 | 157 | 7 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.16e-06 | 200 | 157 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Serous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.16e-06 | 200 | 157 | 7 | 61bae10c8b12196d9cee766897971b81cb897191 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.49e-05 | 149 | 157 | 6 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.49e-05 | 149 | 157 | 6 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-05 | 152 | 157 | 6 | 4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-05 | 152 | 157 | 6 | ebce79e106bf1d84241f8dd3496ff1771f9666be | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 157 | 157 | 6 | a9e077f686382303f0437ebfa4f11d273ba9fe40 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 157 | 157 | 6 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-SMG_basal_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.08e-05 | 158 | 157 | 6 | adad97e6cf479d42791c5ba9cbc5f15f469322bf | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-05 | 160 | 157 | 6 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.41e-05 | 97 | 157 | 5 | f3c3fb260954f594a9ab8e1ac9a01115767cbc7a | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.94e-05 | 168 | 157 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-05 | 169 | 157 | 6 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 169 | 157 | 6 | 15a9183c838cc6384d7f5dfeae3d30602964c9b3 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.14e-05 | 170 | 157 | 6 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-05 | 171 | 157 | 6 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 3.35e-05 | 172 | 157 | 6 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 173 | 157 | 6 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-05 | 173 | 157 | 6 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | wk_15-18-Hematologic-Myeloid-aDC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.69e-05 | 175 | 157 | 6 | c31178d7a5a19d7afd336c9ec0e5c493655a6aa4 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-05 | 176 | 157 | 6 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.93e-05 | 177 | 157 | 6 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.93e-05 | 177 | 157 | 6 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | Dividing_Macrophages-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 4.06e-05 | 178 | 157 | 6 | 6557688c6790a5bcc3b9aea5b8789cf9506b3c54 | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.06e-05 | 178 | 157 | 6 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-05 | 178 | 157 | 6 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | 4.18e-06 | 46 | 154 | 5 | DOID:5426 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | TFEC AMPD1 STARD8 SALL3 NRCAM TYMP SLC1A7 HIVEP3 PROM1 NPAP1 ACIN1 MCRS1 DMRTA1 CUX1 SORL1 | 4.43e-06 | 702 | 154 | 15 | C0009402 |
| Disease | platelet crit | DENND2A TFEC MAP1A TTC28 ERAP1 BACH2 DACH1 RREB1 JMJD1C LEPR CDK13 DMRTA1 RPRD2 MPHOSPH9 CUX1 GP1BA SORL1 | 1.07e-05 | 952 | 154 | 17 | EFO_0007985 |
| Disease | Ankylosing spondylitis | 2.23e-05 | 11 | 154 | 3 | C0038013 | |
| Disease | congenital heart disease (implicated_via_orthology) | 3.12e-05 | 69 | 154 | 5 | DOID:1682 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | STARD8 NRCAM BCORL1 TACC2 COG3 ZNF365 LEPR RIF1 CLCN1 BRCA2 ANKRD30A NCOA1 DLEC1 USP54 CUX1 DOP1A SORL1 | 4.88e-05 | 1074 | 154 | 17 | C0006142 |
| Disease | tyrosine measurement | 2.20e-04 | 104 | 154 | 5 | EFO_0005058 | |
| Disease | cholangiocarcinoma (is_marker_for) | 3.55e-04 | 64 | 154 | 4 | DOID:4947 (is_marker_for) | |
| Disease | stimulant use measurement | 4.15e-04 | 28 | 154 | 3 | EFO_0600076 | |
| Disease | squamous cell carcinoma | 4.24e-04 | 67 | 154 | 4 | EFO_0000707 | |
| Disease | proteinuria (implicated_via_orthology) | 5.10e-04 | 30 | 154 | 3 | DOID:576 (implicated_via_orthology) | |
| Disease | eicosapentaenoic acid measurement | 5.63e-04 | 31 | 154 | 3 | EFO_0007760 | |
| Disease | Abnormality of radial ray | 6.78e-04 | 33 | 154 | 3 | C4228778 | |
| Disease | female breast cancer (is_implicated_in) | 7.42e-04 | 8 | 154 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | Disorder of eye | 8.91e-04 | 212 | 154 | 6 | C0015397 | |
| Disease | neutrophil count | HNF1A HIVEP1 TTC28 BACH2 BCORL1 ASH1L TEX14 RREB1 JMJD1C LEPR LRIG2 HIVEP3 AP4E1 IL1R2 NCOA1 RPRD2 MYRF | 9.22e-04 | 1382 | 154 | 17 | EFO_0004833 |
| Disease | breast carcinoma | TTC28 ASH1L TACC2 RREB1 ZNF365 JMJD1C HIVEP3 SLC12A2 BRCA2 ANKRD30A MAST1 NCOA1 CUX1 DNAH11 | 9.40e-04 | 1019 | 154 | 14 | EFO_0000305 |
| Disease | 22q11 partial monosomy syndrome | 9.51e-04 | 9 | 154 | 2 | C3266101 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | TSHZ3 HIVEP1 TTC28 DACH1 TACC2 RYR2 ALMS1 PCDH15 C2orf49 CUX1 PDE11A SORL1 | 1.05e-03 | 801 | 154 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | testosterone measurement | HNF1A STARD8 ANK3 MAP1A TTC28 BCORL1 DACH1 RREB1 JMJD1C LEPR CDCA2 IL1R2 PGAP1 NCOA1 NDRG4 KNL1 | 1.06e-03 | 1275 | 154 | 16 | EFO_0004908 |
| Disease | age at menopause | 1.08e-03 | 302 | 154 | 7 | EFO_0004704 | |
| Disease | Asymmetric crying face association | 1.18e-03 | 10 | 154 | 2 | C0431406 | |
| Disease | 22q11 Deletion Syndrome | 1.18e-03 | 10 | 154 | 2 | C2936346 | |
| Disease | level of Phosphatidylcholine (18:0_22:5) in blood serum | 1.18e-03 | 10 | 154 | 2 | OBA_2045096 | |
| Disease | Fanconi anemia (is_implicated_in) | 1.18e-03 | 10 | 154 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | retinal vasculature measurement | 1.64e-03 | 517 | 154 | 9 | EFO_0010554 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 1.68e-03 | 45 | 154 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 1.68e-03 | 45 | 154 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 1.73e-03 | 12 | 154 | 2 | EFO_0800500 | |
| Disease | coronary artery disease (is_implicated_in) | 1.90e-03 | 100 | 154 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | schizophrenia, anorexia nervosa | 2.03e-03 | 48 | 154 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | mood disorder | 2.03e-03 | 13 | 154 | 2 | EFO_0004247 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.03e-03 | 13 | 154 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | creatinine measurement | AMPD1 HNF1A INTU DACH1 RREB1 SLC1A7 AP4E1 MLIP ALMS1 USP32 DLEC1 CUX1 SORL1 | 2.22e-03 | 995 | 154 | 13 | EFO_0004518 |
| Disease | Fanconi anemia | 2.36e-03 | 14 | 154 | 2 | cv:C0015625 | |
| Disease | C-X-C motif chemokine 11 measurement | 2.36e-03 | 14 | 154 | 2 | EFO_0008057 | |
| Disease | attempted suicide | 2.48e-03 | 178 | 154 | 5 | EFO_0004321 | |
| Disease | carotid artery intima media thickness | 2.59e-03 | 450 | 154 | 8 | EFO_0007117 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 2.72e-03 | 15 | 154 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | mean platelet volume | STARD8 PCDHGB7 TTC28 ERAP1 NACA BCORL1 FRYL JMJD1C LEPR DENND2C SV2C CUX1 GP1BA | 2.75e-03 | 1020 | 154 | 13 | EFO_0004584 |
| Disease | Ischemic stroke, fibrinogen measurement | 3.00e-03 | 55 | 154 | 3 | EFO_0004623, HP_0002140 | |
| Disease | Nasal Cavity Polyp | 3.00e-03 | 55 | 154 | 3 | EFO_1000391 | |
| Disease | DiGeorge Syndrome | 3.10e-03 | 16 | 154 | 2 | C0012236 | |
| Disease | CONOTRUNCAL ANOMALY FACE SYNDROME | 3.10e-03 | 16 | 154 | 2 | C0795907 | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 3.10e-03 | 16 | 154 | 2 | DOID:3211 (implicated_via_orthology) | |
| Disease | Shprintzen syndrome | 3.10e-03 | 16 | 154 | 2 | C0220704 | |
| Disease | idiopathic pulmonary fibrosis | 3.32e-03 | 57 | 154 | 3 | EFO_0000768 | |
| Disease | fibrinogen measurement, factor VII measurement | 3.49e-03 | 58 | 154 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | insulin resistance | 3.66e-03 | 59 | 154 | 3 | EFO_0002614 | |
| Disease | serum urea measurement | 3.66e-03 | 195 | 154 | 5 | EFO_0009795 | |
| Disease | Bone marrow hypocellularity | 3.92e-03 | 18 | 154 | 2 | C1855710 | |
| Disease | level of Phosphatidylcholine (16:0_22:5) in blood serum | 3.92e-03 | 18 | 154 | 2 | OBA_2045079 | |
| Disease | lung carcinoma | 3.92e-03 | 482 | 154 | 8 | EFO_0001071 | |
| Disease | response to opioid | 4.02e-03 | 61 | 154 | 3 | EFO_0008541 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 4.02e-03 | 61 | 154 | 3 | DOID:3587 (is_marker_for) | |
| Disease | obsolete_red blood cell distribution width | USP36 HNF1A TTC28 TYMP CDCA2 MROH8 SLC12A2 MUC17 FANCI PRKAG1 MAST1 SV2C DMRTA1 FDXACB1 KNL1 | 4.71e-03 | 1347 | 154 | 15 | EFO_0005192 |
| Disease | magnesium measurement | 5.02e-03 | 66 | 154 | 3 | EFO_0004845 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPSISITTESLKSLI | 861 | Q9UKV3 | |
| KLSNSSSSVSPLILS | 141 | Q9BVC5 | |
| LIPTSSKLVVFDTSL | 41 | P54619 | |
| SITKSVELSGLPSTS | 346 | Q9BYV9 | |
| VSPDSLKPVSLTSSL | 6 | Q6UXG8 | |
| TKTPSALEPLSSSTL | 836 | Q5SNV9 | |
| SLIPPETSTVLSSLK | 1231 | Q9NR48 | |
| LSILAETASPSLSKE | 356 | P13611 | |
| SDITILTPKLLSTSP | 736 | P39880 | |
| TLLATTISELSELTP | 681 | Q9H116 | |
| VLTPVHTSSKALLST | 646 | Q5H9F3 | |
| SSRSLEPTSKLLTSK | 3091 | Q8TCU4 | |
| ASLTPLLLSITKRSE | 171 | Q9BXX3 | |
| LRTSFKTITSIPESS | 2361 | Q96DT5 | |
| KTITSIPESSLVQTL | 2366 | Q96DT5 | |
| SDRLSLLSTSSETIP | 1076 | Q5JWR5 | |
| TVNLSIPLSETSSTK | 81 | P23109 | |
| PLLSASIASTKTVIA | 2206 | Q8TDJ6 | |
| STPTARDSLDKLSLT | 581 | Q9UI36 | |
| SSISPSTLTLKSSLA | 436 | Q14004 | |
| TVVKPLILATEATSS | 1896 | Q2TAZ0 | |
| SSLKATVSAPTTTLK | 61 | Q9UPM8 | |
| TAAVRPKSLAISSSL | 156 | Q5VWP3 | |
| PKSLAISSSLVSDVV | 161 | Q5VWP3 | |
| KVDSSVLGSLSSVPL | 276 | Q9UKX7 | |
| ASKEPLTTSLAPTLT | 1736 | Q9HC84 | |
| LTTSLAPTLTSELST | 1741 | Q9HC84 | |
| EVAALKTLVLSSSPT | 251 | Q96QF0 | |
| PLSSSKTITLHITDV | 431 | Q9Y5F8 | |
| VTVLTSLSKLLEPSS | 986 | Q9NVI1 | |
| GTKLTRTISLPTSES | 2176 | Q8WXI7 | |
| KIPLALDTSTLETSA | 4691 | Q8WXI7 | |
| TPSLISSTLPEDKLS | 5051 | Q8WXI7 | |
| EKTSSSSSLLSLPAI | 6506 | Q8WXI7 | |
| ISSLSPKLRETGSSV | 7241 | Q8WXI7 | |
| SLPVTSLLTSGLVKT | 9171 | Q8WXI7 | |
| EKTSSSSSLLSLPVT | 10016 | Q8WXI7 | |
| LALTDISFSSVTVPK | 66 | Q8NGS2 | |
| VTKHSTLLSVPDSTL | 56 | Q6ZWB6 | |
| SITAVTVNKSLLTPL | 136 | Q9NSB2 | |
| SLLLDTVTSIPSSRT | 866 | P78559 | |
| VDPVISKRLSSSSAT | 191 | Q14244 | |
| PLLSKSQSILISTSA | 331 | Q49MG5 | |
| TRSLTLSSLESILAP | 1861 | Q5T1H1 | |
| NPSLKSLVTISVDTS | 81 | P0DP07 | |
| SSLKIVNPTLDSLTL | 956 | Q92823 | |
| VSLTSVIKSPATLLA | 2001 | Q5HYC2 | |
| TRSSTLETTKSPLII | 691 | Q15652 | |
| LLSSLLALLTVSTPS | 16 | Q9NZ08 | |
| NTTPLSTLVTTLLTT | 1061 | Q02505 | |
| KRLLASTASSSPASV | 911 | Q9HCR9 | |
| LRLTSKSLPDLTSSV | 426 | O15018 | |
| KEISSTSQTLLPDLS | 386 | P35408 | |
| RELSLSSVTPTLSQL | 161 | Q6ZU69 | |
| KELSLASVTPTLSQL | 161 | A6NFA0 | |
| LKQPLTATTLSDVLS | 1836 | O94915 | |
| KSTIELSENSLLPAS | 566 | Q5TB30 | |
| LPETLEKTFISLSST | 226 | Q99550 | |
| TLQSLSTEKPSTVVL | 326 | Q9NP85 | |
| DTTNLSALASLTPTK | 526 | P20823 | |
| PTTVVSLLSTTDLEK | 936 | P48357 | |
| SLSNPLSISLTDRKT | 576 | Q8NG31 | |
| LESLTLTGTKISSIP | 321 | Q9BXB1 | |
| ISQILTTSPSLKSLS | 886 | P59047 | |
| LSLVDTLLSSTTVPK | 66 | O60431 | |
| LALTDISFSSVTVPK | 66 | Q8NGS3 | |
| TSIPSTLVSFLSERK | 76 | Q8NGS8 | |
| TSIPSTLVSFLSERK | 76 | Q8NGS9 | |
| SLTIKSIITLPSVRT | 181 | Q9H579 | |
| RVLLTASTLKSIPTS | 216 | Q15466 | |
| LTLETPLTSKRNSTA | 321 | P46093 | |
| SPSLKSRLTITKDTS | 81 | P01817 | |
| PSLKSRVTISVDTSK | 81 | P0DP08 | |
| TSNRKSLILTSTSPT | 31 | Q9Y2H9 | |
| LALTDISLSSVTVPK | 66 | Q8NGS1 | |
| EKTDSLTTSPILSRL | 666 | Q9ULD6 | |
| FSTLPTVSRTVELKS | 1671 | Q96QU1 | |
| LIPSVKSITALALSS | 366 | Q13467 | |
| EISTKLTLINFTLSP | 3336 | Q9P2D7 | |
| LSLKRLTLTTSQSLP | 421 | Q9BYI3 | |
| IPKGTTILTSLTSVL | 381 | P33261 | |
| LIALATSSSSATLPI | 336 | O00341 | |
| ASTLILTPTSKDVLS | 766 | P51587 | |
| TSSIPDTLTKQSLSK | 406 | Q9ULE3 | |
| LISSLSESPASVSIL | 56 | Q9Y6R7 | |
| SLTSQSLPIELTSVV | 66 | Q96JB2 | |
| DLTATKASLPTVSSR | 311 | Q5VZB9 | |
| TTLSTIARKSLPKVS | 316 | P18507 | |
| ALKLSTPSSLSSSQE | 1886 | Q12955 | |
| ATLAITTLLKTGSES | 341 | Q9UBF2 | |
| SKLTKDTTLPVTLTE | 376 | Q68D51 | |
| IRLTSKFTSSSDIPV | 56 | Q6P1S2 | |
| ASLVTAKLVNTTITP | 666 | Q86V48 | |
| VSATSLITPKSTFLT | 466 | P07359 | |
| STFLTTTKPVSLLES | 476 | P07359 | |
| LLSKVGSTSQPTLET | 216 | Q96EZ8 | |
| AVLSSPNKSSISETL | 466 | Q69YH5 | |
| ATLAITTLLKTGSES | 341 | Q9Y678 | |
| TASLALEKTESSLPV | 226 | Q12951 | |
| VLTKSTSLPSLSQLE | 5301 | Q8NDH2 | |
| RSVSTSPSILTAFLK | 331 | Q6ZVF9 | |
| SLLTQTLPESSKLSS | 421 | Q9BRP7 | |
| TKTTITLINGTLLPT | 986 | Q9Y238 | |
| ESPLLVTKSQSLTAL | 196 | Q92622 | |
| ITPESILSALSKTQT | 516 | Q5VT52 | |
| APSTNVTLEALLSTK | 161 | Q9BXA9 | |
| SLDSKPVLVTTSVGL | 471 | Q9UJQ4 | |
| KASTVDLPIESVSLS | 441 | Q92736 | |
| ILVESSTFVSSPTKL | 2011 | Q6ZTR5 | |
| SVTLTITAISTPLEK | 141 | Q70SY1 | |
| SLSRTTATIAPILSV | 436 | Q9UJU5 | |
| LSTLDILFTTTTVPK | 71 | A6NND4 | |
| SSVPSTLVSLISKKR | 106 | Q8NGS6 | |
| SSSSLSPLLLVSVVR | 11 | Q9BZA8 | |
| TSIPSTLVSFLSERK | 76 | Q8NGT0 | |
| GSTLLTSIPVSTTLV | 1276 | Q685J3 | |
| PLSTTLVVSSEASTL | 1991 | Q685J3 | |
| ERSTLLTTVLISPIS | 3811 | Q685J3 | |
| ISITSERSTPLTTLL | 3866 | Q685J3 | |
| ERSTPLTTLLVSTTL | 3871 | Q685J3 | |
| ALASLPSAIFSTTVK | 226 | Q9NSD7 | |
| SIKITTVSLSAPDAL | 2016 | Q92673 | |
| SLVSITKSIPILLAS | 691 | Q496J9 | |
| LSSLSLPESTREAKS | 706 | Q8IWB6 | |
| SPLSDSILAEKTITV | 646 | Q8N3T6 | |
| VSSSISAFTLPVIKL | 281 | Q86VY9 | |
| SISTLELFTVPLSTE | 461 | Q15345 | |
| ATTLLPSSGLVTLEK | 821 | O14513 | |
| GDLSTLTASEIKTLP | 2331 | Q5UIP0 | |
| TSVTIKSEILPASLQ | 841 | Q15788 | |
| IPSIEISASSKQISL | 641 | Q5QGS0 | |
| LTSVKTSLRSSLNDP | 291 | O43490 | |
| ETLRSKSLPVLSSAS | 31 | Q9H2Y9 | |
| LSTFLSEPVVKALTS | 141 | Q8NG04 | |
| PLLVSVSALTLATET | 511 | P50991 | |
| ATKLSGLTSTLPDTV | 151 | Q9ULP0 | |
| LTIAQAPSSTEISLK | 536 | Q75T13 | |
| SVTKAPLILTSVAIS | 716 | Q9BZV3 | |
| PLILTSVAISASTDK | 721 | Q9BZV3 | |
| LVSSASAASLSKPAI | 806 | Q9NZP6 | |
| SPLKTISASLGSRLT | 241 | P27930 | |
| TAAILTPLTDSKIIS | 411 | Q9NP91 | |
| TELSATSLPVITVSL | 71 | Q92502 | |
| LKTTDLSIQPASTDL | 1041 | Q8IVF2 | |
| LKTTDLSIQSPSADL | 1701 | Q8IVF2 | |
| LKTTDLSIQSPSADL | 4176 | Q8IVF2 | |
| KSSIGLSTIPLSSSE | 4726 | Q8IVF2 | |
| PVLKTTSEIFLSSTA | 116 | Q8IWZ3 | |
| TTTVKTLPLVDSKDS | 631 | P35523 | |
| FLSSNITSSSKITIP | 361 | Q53H76 | |
| KTPRVSLAGLETLSS | 116 | P0C879 | |
| ASLVSSISATKSLLP | 141 | Q9Y330 | |
| PSLKDTDLVTSSELL | 66 | Q70YC5 | |
| LLSSVSPAVSKASSR | 551 | P19532 | |
| IISSVSSAPTLLKTK | 1071 | Q92766 | |
| VSISSPVLSLSSLLR | 126 | O15533 | |
| TLSSALASLVSAPKI | 611 | P55011 | |
| RTTIISSLPEFEKSS | 601 | Q92545 | |
| PSTTASKISALEGLL | 206 | O60667 | |
| LAPSIRTKTISATAT | 1511 | P24821 | |
| TLPERKGTSLSSESI | 1401 | Q5T1R4 | |
| DLSSITDPLIKSTIL | 2786 | Q6ZS81 | |
| KTTTPESDLGTLRLT | 2551 | Q9P273 | |
| EQQSSLLKLSSTTPT | 481 | D6RCP7 | |
| VPISKSTLSRSLSLQ | 2076 | O95359 | |
| SSTSLRSTTLEKEVP | 1376 | Q86X10 | |
| KPLASSLSGSTAIIT | 696 | Q63HK5 | |
| EQQSSLLKLSSTTPT | 481 | C9JPN9 | |
| TELPKRLSLDSSSSL | 1941 | Q96AY4 | |
| EIQRTSLSEKSPLSS | 31 | P0C7H9 | |
| LLSATSPAVSKESSR | 321 | O14948 | |
| PRTKDGSLVSLSLTS | 326 | Q9GZL7 | |
| EQQSSLLKLSSTTPT | 481 | D6RA61 | |
| LTLSTLSLAKTTQPI | 11 | A0A0B4J268 | |
| KSSTLSLPRVSLSDT | 86 | A0A0B4J268 | |
| ATVDSLPLITASILS | 206 | P19971 | |
| IKSSTSLTLTVRSSP | 1861 | P15822 | |
| VLLSKSPSSLSANII | 1356 | Q8NFA0 | |
| DVVLSTSPKLLATAT | 576 | Q9P275 | |
| EISRLSISQKLPSTT | 101 | Q9P2T0 | |
| SSPSRSALKLLTSVE | 946 | Q70EL1 | |
| SLTSLAKLPSETIFV | 301 | P57678 | |
| LSSNIISEIKTSSFP | 151 | O94898 | |
| VATSFSLSPTTSLIL | 401 | E9PAV3 | |
| IQPSLLLVTTSLTSS | 851 | Q9Y2G1 |